Ask most founders when dilution gets painful and they will say Series A. That’s when institutional money arrives, term sheets get negotiated, and lawyers start earning their fees. It is also, for many of them, the moment they realize the painful part already happened.
The instruments that did the damage were signed months or years earlier, in short documents that required no valuation negotiation and took less than an afternoon to close. Pre-seed SAFEs, stacked one after another as the company grew, convert all at once when the first priced round closes. By then the founder is looking at a cap table that shows far less ownership than they expected. There is nothing left to negotiate.
Data from Carta shows median founding-team ownership at 56.2% after a Seed round, falling to 36.1 percent by Series A. But the drop that precedes those figures is steeper. According to altshare’s data, drawn from thousands of founder cap tables, median founding-team ownership sits at roughly 87 percent at pre-seed, falling to about 52 percent at seed rounds. That gap of around 35 percentage points is larger than any other transition between funding stages. The steepest dilution is not at Series A. It is the stage before it.
Why founders miss it until it is too late
Part of what makes this so easy to miss is that it never feels like one decision. A SAFE signed with an angel in March, another with a fund in June, maybe a third a year later. Each one is short, fast to close, and seems entirely reasonable on its own. The exact cost depends on a round that has not happened yet, but it can be modeled against a few possible prices. Most founders never do that for the full stack until the priced round forces them to.
This Morning
The daily digest for entrepreneurs and business leaders
Here is the part most founders overlook. The cap is not a valuation. It is a ceiling on what that specific investor pays when the SAFE converts, which means a strong round does nothing to reduce what they got. An early angel who signed at a $5 million cap is not moved by a $15 million priced round. Their terms were set at signing. Throw in a discount clause, and they are also entering below whatever price the new investors pay. When a SAFE has both, the investor picks the better deal for themselves. Run enough of those instruments through a single priced round and the math gets uncomfortable quickly.
I spoke with Ronen Solomon, co-founder and CEO of altshare, whose platform has tracked this across thousands of founder cap tables. “Nobody experiences it as one decision,” he told me. “It is a SAFE signed with an angel in March, another with a fund in June, maybe a third a year later, and an option pool number the lead suggests in the last week of the round. Each one feels small and reasonable at the time. Then those SAFEs convert on the same day, and the founder sees the whole bill at once.”
The specific mistakes that make it worse
Treating the cap as a valuation is the most common error. A SAFE cap is not a valuation. It is a ceiling on the conversion price for that investor. Founders who read it as a signal of what the company is worth tend to sign caps that are far too low relative to where the company will price its first round, and the gap between those numbers is where equity quietly transfers.
